Search results

Selected filters:

North America
Market Developments

Article type

Topic

Sector

Jurisdictions

439 results found for your search

Sort options
23 October 2019

IBM patent transaction puts Indian IT firm on par with rivals

Around 200 patents change hands as Big Blue selloff continues and a new HCL IP executive strikes first known deal

19 October 2019

Why the Red Hat tail will end up wagging the Big Blue dog

IBM's decision to purchase the open source powerhouse was a $34 billion bet on the future and from an IP perspective something has to give

09 October 2019

Intel can’t knock out Chinese state lab’s chip patent

Invalidation efforts in both China and the United States have come up short as the US chip giant faces Chinese infringement claims

09 October 2019

IBM has the world's most valuable patent portfolio, new analysis claims

Samsung, Canon, Microsoft and Bosch round-out the top five who, between them, are said to own assets worth well in excess of $35 billion

08 October 2019

New wave of company blacklistings in the US will accelerate Chinese tech’s inward turn

Eight Chinese entities – including leaders in AI, facial recognition and data forensics - added to Bureau of Industrial Security entity list

05 October 2019

The USPTO seeks AI expertise to change the rules of the game internally and externally

New role has the potential to deliver results that will enhance internal processes, improve quality, lower costs and help recover lost US influence in the international IP arena

04 October 2019

The new China dynamic, pool progress and more from our Patent Licensing event

The big takeaways from a day of deal-making discussions in the heart of Silicon Valley

03 October 2019

Chip foundries bring high-stakes patent litigation to Singapore

TSMC hits back against Globalfoundries with countersuits in the US, Germany and Singapore. The headline grabbing dispute takes place as the Lion City attempts to lure more cases with legal reforms

30 September 2019

ITRI spin-out is plaintiff in latest genomics patent campaign

Taiwan’s Personal Genomics is going after an acquisition target of Illumina, the top player in the sequencing space

27 September 2019

Huawei’s FRAND strategy: move cases to China

The company wants to shift disputes to its home jurisdiction and persuade courts there to set a low, China-specific rate

26 September 2019

Allegations of sham pharma patent litigation are growing, but claimants have a mountain to climb

Akorn Inc’s failure to make its case against Allergan and Duke is a reminder that challenging life sciences patentees remains a tough task

21 September 2019

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

16 September 2019

Genentech dispute highlights growing importance of trade secrets for life sciences companies

Legal and commercial developments suggest that disputes over increasingly valuable biopharma know-how, proprietary information and data will increase in years to come.

10 September 2019

IP boutique seeks to show that new thinking on diversity is not just for Big Law

“We’re in a field of innovation but firms don’t do anything,” claims Harrity & Harrity managing partner John Harrity  on launch of incubator project

06 September 2019

New analysis points to long-term decline in US patent prosecution

The continuing shift from quantity to quality, and perhaps more reliance on trade secrets, have led to patentees cutting back on filing applications